About Us

The Company

Palo Alto Health Sciences, Inc. is a privately held Silicon Valley digital therapeutic company at the forefront of revolutionizing behavioral healthcare with evidence based, at-home, drug-free solutions. Our product, Freespira®, is an FDA-cleared treatment for individuals suffering from panic disorder, panic attacks and other symptoms of panic.

Our Mission

To improve quality-of-life of people suffering from debilitating panic attacks and anxiety disorders, reduce medical costs, and support the appropriate utilization of valuable healthcare resources.

Press Releases

Highmark Inc. Adds Coverage For Medical Innovations In Treatment Of Panic Attacks [...]

September 24, 2018 | News

PITTSBURGH, Pa. (Sept. 17, 2018) — A new, non-pharmaceutical treatment, Freespira, and non-invasive diagnostic technology, Heartflow FFRct (fractional flow reserve), …

Multiple Studies Show Freespira® Eliminates Panic Attacks in 80% of Patients

April 11, 2018 | News

50% Reduction in Health Costs One Year Post-Treatment Also Demonstrated Danville, CA – (April 11 , 2018) – Palo Alto Health …

Anxiety and Depression Assoc. of America. 2018 Annual Conference. Kaplan, M.D. Freespira Study

April 10, 2018 | News

Abstract Presentation

Palo Alto Health Sciences Accelerates Commercialization of Freespira®

March 14, 2018 | News

Palo Alto Health Sciences Accelerates Commercialization of Freespira® Company is expanding focus on bridging mental and physical health in employer and …

Highmark Health’s VITAL Innovation Program Validates Effective Drug-Free Treatment for Panic Attacks

November 28, 2017 | News

Highmark Health’s VITAL Innovation Program Validates Effective Drug-Free Treatment for Panic Attacks At 12 months post-treatment, participants’ total medical costs reduced …

Palo Alto Health Sciences Names Amy Perry to Board of Directors

August 17, 2017 | News

Danville, CA – (August 17, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® treatment for panic …

Freespira® Clinical Data to be Presented at Three Upcoming Conferences

May 17, 2017 | News

Danville, CA – (May 17, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® at-home treatment for …

Palo Alto Health Sciences Partners with Silicon Valley TMS Integrated Clinical Neurosciences to Offer Freespira® Treatment for Panic Attacks and Panic Disorder

May 2, 2017 | News

Danville, CA – (May 2, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® treatment for panic …

Next Generation Freespira® System for Panic Attacks to be Unveiled at Anxiety and Depression Association of America Conference

April 4, 2017 | News

Danville, CA – (April 4, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® at-home treatment for …

New Freespira® Study Shows Nearly 80% of Patients are Panic Attack Free at One Year Post-Treatment

February 22, 2017 | News

The drug-free, four-week at-home treatment produces lasting results Danville, CA – (February 22, 2017) – Palo Alto Health Sciences, Inc. (PAHS), …

Clinical Results of Drug-Free Freespira® Treatment for Panic to be Presented at Clinical TMS Society Annual Meeting

February 17, 2017 | News

Danville, CA – (May 15, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of Freespira®, the only FDA-cleared digital …

Freespira In the News

New Device Shows Encouraging Signs In Helping Reduce Panic Attacks: CBS Pittsburgh, September 2018

Panic sufferers take life back from grip of fear: Pittsburgh Post-Gazette, January 2018

Study finds breathing device treats panic attacks – and lowers medical costs: Philadelphia Inquirer, November 2017

Highmark Health’s VITAL Innovation Program Validates Effective Drug-Free Treatment for Panic Attacks: Highmark Health, November 2017

Time to Stop Panicking!: Psychology Today, May 2016

Re-Learning to Breathe With Freespira Can Ease Panic Symptoms: Highmark Health Blog, March 2015

A new way to banish panic attacks: ABC 7 Chicago, March 2016

New medical device helps with panic attacks: ABC 7 Los Angeles, April 2016